You get this chance only once in a lifetime. News next week with a more recent recommendation by an analyst of $3.00 price target (2 - 2 1/2 months ago) could rocket this stock upwards. But with the R/S potential, I see this staying between $0.20 - $0.75 / share until the R/S ratio is determined my management, if they should choose to take this route. I feel that they will partner instead by early June with a huge chunk of cash that they will use to retire the $12 million bonds and announce that the R/S will not be necessary. Smart investors will definitely turn down the R/S since the management stated that the shares outstanding will remain unchanged. Never heard of such language in a R/S before.
Was this loan actually given to the company by the 2 officers so that they could become ungodly wealthy once the EMA or the FDA approved one of their drugs?
A 200-bagger happened yesterday with shsnq.pk Shearson. It was .0002 on Wednesday and peaked at .04 yesterday. Ended the day at .033 or close. $20 became $4,000 in two days. I'd like to see GNTA.OB do that, also.